| Up
2006P-0049:
Reduce the Public Health Risks Associated with the Use of Drugs
Manufactured or Processed at Foreign Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 01/24/2006
|
| 01/24/2006
|
| Association
|
| Synthetic Organic
Chemical Manufacturers Association's
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Barbara Zinck
|
|
|
|
|
|
| ACK1
|
| 01/23/2006
|
| 01/23/2006
|
| Federal Government
|
| HFA-305 to Litron
Laboratories
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
| LET1
|
| 07/20/2006
|
| 07/20/2006
|
| Federal Government
|
| FDA/CDER to Synthetic
Organic Chemical Manufacturers Association's
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
| |
Top | Up
Page last updated
August 14, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
